X4 Pharmaceuticals, Inc. (XFOR)

3.87 -0.04 (-1.02%) USD  |  NASDAQ  |  Dec 15, 14:42
More

X4 Pharmaceuticals Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for XFOR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Altimmune, Inc. Upgrade
Adverum Biotechnologies, Inc. Upgrade
Hims & Hers Health, Inc. --
Recursion Pharmaceuticals, Inc. Upgrade